Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma

The lack of information concerning individual variation in drug-metabolizing enzymes is one of the most important obstacles for designing personalized medicine approaches for hepatocellular carcinoma (HCC) patients. To assess cytochrome P450 (CYP) in the metabolism of endogenous and exogenous molecu...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Oncotarget
Autors principals: Zhou, Jun, Wen, Qiang, Li, Sai-Fei, Zhang, Yun-Fei, Gao, Na, Tian, Xin, Fang, Yan, Gao, Jie, Cui, Ming-Zhu, He, Xiao-Pei, Jia, Lin-Jing, Jin, Han, Qiao, Hai-Ling
Format: Artigo
Idioma:Inglês
Publicat: Impact Journals LLC 2016
Matèries:
Clinical Research Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5226607/
https://ncbi.nlm.nih.gov/pubmed/27203676
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.9437
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars